RESEARCH STARTER
Calcium channel blockers (drug interactions)
Calcium channel blockers (CCBs) are a class of medications primarily used to treat conditions such as hypertension, angina, and certain heart arrhythmias. While effective in managing these heart-related issues, CCBs can interact with various substances, potentially altering their effectiveness. Key interactions involve calcium and vitamin D supplements, which may reduce the action of CCBs. Additionally, Ginkgo biloba may hasten the metabolism of these drugs, leading to diminished therapeutic effects. The citrus bioflavonoid naringin is known to increase the blood levels of CCBs, possibly necessitating dosage adjustments. Other herbs and supplements, including St. John's wort and hawthorn, can also affect how CCBs work, with some potentially lowering blood pressure to unsafe levels. It is crucial for individuals taking CCBs to be aware of possible interactions with other prescription medications, such as statins and antifungals, as well as common dietary components like grapefruit juice. Consulting with healthcare providers about these interactions is vital for safe and effective treatment.
Authored By: EBSCO CAM Review Board 1 of 4
Published In: 2024 2 of 4
- Related Topics:
3 of 4
- Related Articles:A Dark Side of Calcium Channel Blockers: Increased Risk of Stasis Dermatitis.;Calcium channel blockers and beta blockers in pediatric supraventricular tachycardia.;Research from Johnson & Johnson Reveals New Findings on Bipolar Disorders (Lack of association between the brain penetrance of calcium channel blockers and the incidence of neuropsychiatric outcomes: a retrospective, multidatabase cohort study).;University of Florida College of Pharmacy Researcher Discusses Findings in Depression (Risk of Fractures With Concomitant Use of Calcium Channel Blockers and Selective Serotonin Reuptake Inhibitors).
4 of 4
Full Article
DEFINITION: Medications used to treat hypertension, angina, heart arrhythmia, and other heart-related conditions.
- INTERACTIONS: Calcium, Ginkgo biloba, naringin (a citrus bioflavonoid), vitamin D, and many others
- DRUGS IN THIS FAMILY: Amlodipine (Norvasc), diltiazem (Cardizem, Cardizem CD, Cardizem SR, Dilacor XR, Tiamate, Tiazac), felodipine (Plendil), isradipine (DynaCirc, DynaCirc CR), nicardipine hydrochloride (Cardene, Cardene SR), nifedipine (Procardia, Procardia XL, Adalat, Adalat CC), nimodipine (Nimotop), nisoldipine (Sular), verapamil (Calan, Calan SR, Covera-HS, Isoptin, Isoptin SR, Verelan)
Calcium and Vitamin D
Effect: Possible Decreased Action of Drug
Taking calcium and vitamin D supplements might interfere with some of the effects of calcium channel blockers.
Ginkgo biloba
Effect: Possible Decreased Action of Drug
According to a study in rats, ginkgo extract may cause the body to metabolize some calcium channel blockers more rapidly, thereby decreasing their effects.
Naringin (Citrus Bioflavonoid)
Effect: May Necessitate Reduction in Drug Dosage
Some evidence suggests that the bioflavonoid naringin may interact with medications in the calcium channel blocker family, increasing the drug's blood levels. This may necessitate a reduction in drug dosage.
Several other herbs and natural supplements may interfere with calcium channel blockers. St. John’s wort may decrease their effectiveness. When taken with calcium channel blockers, hawthorn may lower blood pressure to dangerous levels. Ginseng, magnesium, and goldenseal may interact adversely with calcium channel blockers. It is also important to remember that other prescription medications may also interact with calcium channel blockers. Patients taking statins, antifungals, antibiotics, and antiarrhythmic medications should talk with their healthcare provider. Finally, grapefruit juice can also interfere with the breakdown of calcium channel blockers in the body.
Bibliography
"Calcium Channel Blockers for High Blood Pressure: Types, Uses, Effects." WebMD, 18 Dec. 2023, www.webmd.com/hypertension-high-blood-pressure/treatment-calcium-channel. Accessed 17 Dec. 2025.
Guadagnino, V., et al. "Treatment of Severe Left Ventricular Dysfunction with Calcium Chloride in Patients Receiving Verapamil." Journal of Clinical Pharmacology, vol. 27, 1987, pp. 407-9.
Horowitz, B. Zane. "Calcium Channel Blocker Toxicity." Medscape, 4 Apr. 2023, emedicine.medscape.com/article/2184611-overview. Accessed 17 Dec. 2025.
Kuhn, M., and D. L. Schriger. "Low-Dose Calcium Pretreatment to Prevent Verapamil-Induced Hypotension." American Heart Journal, vol. 124, 1992, pp. 231-2.
Luscher, T. F., et al. "Calcium Gluconate in Severe Verapamil Intoxication." New England Journal of Medicine, vol. 330, 1994, pp. 718-20.
Margolis, K. L., et al. "Effect of Calcium and Vitamin D Supplementation on Blood Pressure." Hypertension, vol. 52, 2008, pp. 847-55.
McKeever, Rita G., et al. "Calcium Channel Blockers - StatPearls." NCBI, 22 Feb. 2024, www.ncbi.nlm.nih.gov/books/NBK482473. Accessed 17 Dec. 2025.
Full Article
DEFINITION: Medications used to treat hypertension, angina, heart arrhythmia, and other heart-related conditions.
- INTERACTIONS: Calcium, Ginkgo biloba, naringin (a citrus bioflavonoid), vitamin D, and many others
- DRUGS IN THIS FAMILY: Amlodipine (Norvasc), diltiazem (Cardizem, Cardizem CD, Cardizem SR, Dilacor XR, Tiamate, Tiazac), felodipine (Plendil), isradipine (DynaCirc, DynaCirc CR), nicardipine hydrochloride (Cardene, Cardene SR), nifedipine (Procardia, Procardia XL, Adalat, Adalat CC), nimodipine (Nimotop), nisoldipine (Sular), verapamil (Calan, Calan SR, Covera-HS, Isoptin, Isoptin SR, Verelan)
Calcium and Vitamin D
Effect: Possible Decreased Action of Drug
Taking calcium and vitamin D supplements might interfere with some of the effects of calcium channel blockers.
Ginkgo biloba
Effect: Possible Decreased Action of Drug
According to a study in rats, ginkgo extract may cause the body to metabolize some calcium channel blockers more rapidly, thereby decreasing their effects.
Naringin (Citrus Bioflavonoid)
Effect: May Necessitate Reduction in Drug Dosage
Some evidence suggests that the bioflavonoid naringin may interact with medications in the calcium channel blocker family, increasing the drug's blood levels. This may necessitate a reduction in drug dosage.
Several other herbs and natural supplements may interfere with calcium channel blockers. St. John’s wort may decrease their effectiveness. When taken with calcium channel blockers, hawthorn may lower blood pressure to dangerous levels. Ginseng, magnesium, and goldenseal may interact adversely with calcium channel blockers. It is also important to remember that other prescription medications may also interact with calcium channel blockers. Patients taking statins, antifungals, antibiotics, and antiarrhythmic medications should talk with their healthcare provider. Finally, grapefruit juice can also interfere with the breakdown of calcium channel blockers in the body.
Bibliography
"Calcium Channel Blockers for High Blood Pressure: Types, Uses, Effects." WebMD, 18 Dec. 2023, www.webmd.com/hypertension-high-blood-pressure/treatment-calcium-channel. Accessed 17 Dec. 2025.
Guadagnino, V., et al. "Treatment of Severe Left Ventricular Dysfunction with Calcium Chloride in Patients Receiving Verapamil." Journal of Clinical Pharmacology, vol. 27, 1987, pp. 407-9.
Horowitz, B. Zane. "Calcium Channel Blocker Toxicity." Medscape, 4 Apr. 2023, emedicine.medscape.com/article/2184611-overview. Accessed 17 Dec. 2025.
Kuhn, M., and D. L. Schriger. "Low-Dose Calcium Pretreatment to Prevent Verapamil-Induced Hypotension." American Heart Journal, vol. 124, 1992, pp. 231-2.
Luscher, T. F., et al. "Calcium Gluconate in Severe Verapamil Intoxication." New England Journal of Medicine, vol. 330, 1994, pp. 718-20.
Margolis, K. L., et al. "Effect of Calcium and Vitamin D Supplementation on Blood Pressure." Hypertension, vol. 52, 2008, pp. 847-55.
McKeever, Rita G., et al. "Calcium Channel Blockers - StatPearls." NCBI, 22 Feb. 2024, www.ncbi.nlm.nih.gov/books/NBK482473. Accessed 17 Dec. 2025.
More Like ThisRelated Articles
Related Articles (4)
Related Articles (4)
- A Dark Side of Calcium Channel Blockers: Increased Risk of Stasis Dermatitis.Published In: International Journal of Dermatology, 2025, v. 64, n. 8. P. 1526Authored By: Cherradi, Racha; Bouchelkia, Iman; Haque, Safiya; Ezuruike, Jennifer; Pacha, OmarPublication Type: Academic Journal
- Calcium channel blockers and beta blockers in pediatric supraventricular tachycardia.Published In: Journal of Cardiovascular Electrophysiology, 2024, v. 35, n. 11. P. 2237Authored By: Sullivan, John; Pompa, Anthony G.; Schieber, Jonah; Arora, Gaurav; Dionne, Audrey; Beach, CheyennePublication Type: Academic Journal
- Research from Johnson & Johnson Reveals New Findings on Bipolar Disorders (Lack of association between the brain penetrance of calcium channel blockers and the incidence of neuropsychiatric outcomes: a retrospective, multidatabase cohort study).Published In: Mental Health Weekly Digest, 2026. P. 3178Publication Type: Periodical
- University of Florida College of Pharmacy Researcher Discusses Findings in Depression (Risk of Fractures With Concomitant Use of Calcium Channel Blockers and Selective Serotonin Reuptake Inhibitors).Published In: Mental Health Weekly Digest, 2023. P. 2725Publication Type: Periodical